Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Four new luxury hotel openings in Italy you need to know about - 2Baby takes 1st steps after receiving groundbreaking gene-edited therapy
- 3Upgrading the Healthy benefit of Your Local Vegetables
- 4Figure out How to Use Your Nursing Abilities for Better Compensation
- 5Many European nations want Israel to cancel 19 new settlement plans
- Ukraine proved this drone-killer works. Now, the West is giving it a shot.
- Russia’s New KVS Drone May Be Designed To Restore Reach In The FPV War
- From record warming to rusting rivers, 2025 Arctic Report Card shows a region transforming faster than expected
- Argentina joins NASA’s moon return with microsatellite testing GPS beyond Earth
- Industrial zone damaged in Negev, falls in Sharon area after Iran fires missiles towards Israel
- Dutch police probe a small blast outside a pro-Israel Christian center
- The Delight of Perusing: Book Proposals for Each Class
- Terminal cancer diagnosis announced by JFK's granddaughter
- Rediscovering Experience Through Excursions: Individual Travel Stories
